The FDA announced that IV fluid containers of all sizes have been added to its medical device shortages list, with the shortage expected to persist through March 2025.
Supply Chain
On Dec. 3, the FDA finalized its guidance for AI-enabled medical devices.
The Alabama Society for Healthcare Materiel Management marked its 45th anniversary during its Fall Conference in Orange Beach, Ala.
Northwestern Medicine is testing drone deliveries at Delnor Hospital in Geneva, Ill., in collaboration with Valqari.
The Administration for Strategic Preparedness and Response, an HHS agency, is providing $44 million to bolster the U.S. public health supply chain.
Baxter has implemented new allocation levels for several U.S. IV product groups, effective Nov. 26, as part of recovery efforts at its North Carolina manufacturing site.
President-elect Donald Trump's plan to impose tariffs on imported goods is expected to affect the prices of approximately 75% of medical devices marketed in the U.S., according to consulting firm GlobalData's Medsource Database, Medical Device Network reported Nov. 22.
The FDA's Center for Devices and Radiological Health announced a pilot program designed to improve the timeliness of communications regarding high-risk medical device recalls.
Medical device recalls, whether voluntary or mandated, are crucial for ensuring patient safety.
Baxter announced the release of its first 1-liter IV solutions manufactured post-hurricane, marking a significant step in addressing the ongoing IV shortage.